ATE179333T1 - Immunotherapeutische zubereitung - Google Patents

Immunotherapeutische zubereitung

Info

Publication number
ATE179333T1
ATE179333T1 AT94905639T AT94905639T ATE179333T1 AT E179333 T1 ATE179333 T1 AT E179333T1 AT 94905639 T AT94905639 T AT 94905639T AT 94905639 T AT94905639 T AT 94905639T AT E179333 T1 ATE179333 T1 AT E179333T1
Authority
AT
Austria
Prior art keywords
present
preparation
immunotherapeutic preparation
immunotherapeutic
abort
Prior art date
Application number
AT94905639T
Other languages
English (en)
Inventor
Stanley J Alkemade
Graeme Mcrae
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Application granted granted Critical
Publication of ATE179333T1 publication Critical patent/ATE179333T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT94905639T 1993-01-29 1994-01-28 Immunotherapeutische zubereitung ATE179333T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29

Publications (1)

Publication Number Publication Date
ATE179333T1 true ATE179333T1 (de) 1999-05-15

Family

ID=21751403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94905639T ATE179333T1 (de) 1993-01-29 1994-01-28 Immunotherapeutische zubereitung

Country Status (11)

Country Link
US (1) US5759554A (de)
EP (1) EP0681479B1 (de)
JP (1) JPH08508976A (de)
CN (1) CN1102855C (de)
AT (1) ATE179333T1 (de)
AU (1) AU691797B2 (de)
BR (1) BR9406496A (de)
DE (1) DE69418183T2 (de)
DK (1) DK0681479T3 (de)
NZ (1) NZ261094A (de)
WO (1) WO1994016727A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
CA2284932A1 (en) * 1997-04-02 1998-10-08 Nigel C. Phillips Use of bacterial cell wall extracts for treating topical disorders and wounds
PT1003525E (pt) 1997-08-05 2003-03-31 Bioniche Life Sciences Inc Composicao e metodo para a regulacao da proliferacao e da morte celular
WO2000033879A1 (en) * 1998-12-04 2000-06-15 Bioniche Life Sciences Inc. Method for the treatment of inflammation
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
DE60033397T2 (de) * 1999-07-23 2007-05-31 Bioniche Life Science, Inc., Belleville Methode zur steigerung der produktionsleistung in tieren
CZ20022372A3 (cs) * 1999-12-13 2002-11-13 Bioniche Life Sciences Inc. Terapeuticky pouľitelné syntetické oligonukleotidy
US7125858B2 (en) 1999-12-28 2006-10-24 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
KR20020091170A (ko) * 2000-03-31 2002-12-05 아이덱 파마슈티칼즈 코포레이션 Ｂ 세포 림프종의 치료를 위한 항-사이토카인 항체 또는길항제 및 항-ｃｄ２０의 조합된 사용
JP5578390B2 (ja) * 2007-03-05 2014-08-27 株式会社 Ｍｂｒ 細菌細胞壁骨格成分の製造方法
HUE052413T2 (hu) 2010-10-13 2021-04-28 Telesta Therapeutics Inc Bakteriális ribonukleinsav-sejtfalkészítmények és elõállítási és felhasználási módszereik
TR201101874A2 (tr) 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
EP3107566A4 (de) * 2014-02-18 2017-10-11 Advaxis, Inc. Auf biomarker gerichtete multi-target-immuntherapie
WO2017143386A1 (en) * 2016-02-25 2017-08-31 Borody Thomas J Compositions and methods of treatment of chronic infectious diseases
CN113244384A (zh) 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202000002641A1 (it) 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202000002866A1 (it) 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
IT202100013292A1 (it) * 2021-05-21 2022-11-21 Aileens Pharma S R L Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2160326B1 (de) * 1971-11-19 1975-02-07 Anvar
NL7308450A (de) * 1972-06-20 1973-12-27
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
CH602920A5 (de) * 1973-02-23 1978-08-15 Wellcome Found
FR2269961B1 (de) * 1974-05-06 1978-03-24 Anvar
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
FR2551758B1 (fr) * 1983-08-16 1986-01-31 Anvar Derives de muramyl-peptides et de steroides ayant des proprietes d'activation des macrophages
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
AU660430B2 (en) * 1990-11-08 1995-06-29 Stanford Rook Limited Mycobacterium as adjuvant for antigens

Also Published As

Publication number Publication date
CN1102855C (zh) 2003-03-12
DE69418183D1 (de) 1999-06-02
NZ261094A (en) 1998-04-27
WO1994016727A1 (en) 1994-08-04
CN1118574A (zh) 1996-03-13
AU5968094A (en) 1994-08-15
DE69418183T2 (de) 1999-12-16
JPH08508976A (ja) 1996-09-24
DK0681479T3 (da) 1999-11-08
EP0681479A1 (de) 1995-11-15
BR9406496A (pt) 1996-01-02
AU691797B2 (en) 1998-05-28
EP0681479B1 (de) 1999-04-28
US5759554A (en) 1998-06-02

Similar Documents

Publication Publication Date Title
DE69418183D1 (de) Immunotherapeutische zubereitung
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
ES2190784T3 (es) Supresion de enfermedades autoinmunes por antigenos espectadores.
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
KR890700353A (ko) 면역독소의 면역억제 기저 사람치료법
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
SE9601395D0 (sv) New therapeutic treatment 1
ES2177535T3 (es) Vacunas contra protozoos intestinales.
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
CA2154689A1 (en) Improved immunotherapeutic composition
DE3373978D1 (en) Composition for the care or treatment of the human skin
SE8303729L (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
ATE202284T1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
RU93051046A (ru) Способ борьбы с аскосферозом и гнильцовыми болезнями пчел
IT7828549A0 (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento.
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
BG97498U (bg) Средство за лечение на хемороиди и кожни заболявания
RU95111615A (ru) Способ лечения органа или системы с низким уровнем ответной реакции на раздражители при умеренном или высоком уровне врожденной реакции организма в целом
ES489956A0 (es) Sistema para la aplicacion de tratamientos bronceadores y terapeuticos integrales del cuerpo humano
UA30460A (uk) Спосіб лікування системного аутоімунного захворювання
BR9105164A (pt) Composto de peptideo,processo para produzir o mesmo,cepa,agente anti-helm intico,aditivo para racao,processo para tratar ou evitar doenca parasitica e processo para melhorar a eficiencia da racao de um animal

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties